Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Int J Tuberc Lung Dis ; 18(3): 352-6, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24670575

ABSTRACT

SETTING: National Referral Centre for Tuberculosis (TB), Tehran, Iran. OBJECTIVE: To determine the impact of chronic renal failure (CRF) on TB treatment outcomes. DESIGN: A retrospective study was conducted among adult TB patients with CRF and age- and sex-matched TB controls without CRF treated at the National Research Institute of Tuberculosis and Lung Disease from 2004 to 2011. Multivariate analysis was performed to determine the impact of CRF on drug-induced hepatitis (DIH), treatment failure and all-cause mortality. RESULTS: A total of 55 TB cases with CRF and 165 TB cases without CRF were included in the study. Baseline demographic and clinical characteristics were similar, except that TB cases with CRF were more likely to be of Iranian nationality (94.5% vs. 83%, P = 0.04). During anti-tuberculosis treatment, 40 (18.2%) patients developed DIH, none failed treatment and 15 (6.8%) died. Patients with CRF were more likely to develop DIH (27.3% vs. 15.2%, P = 0.04) and to die during treatment (16.4% vs. 3.6%, P = 0.001). CRF remained significantly associated with all-cause mortality (HR 4.87, 95%CI 1.73-13.65) in multivariate analysis, whereas the relationship with DIH was not. CONCLUSION: TB patients with CRF are at increased risk of death. More intensive monitoring of patients with CRF should be considered by the National TB Programme.


Subject(s)
Antitubercular Agents/therapeutic use , Renal Insufficiency, Chronic/complications , Tuberculosis/drug therapy , Aged , Antitubercular Agents/adverse effects , Chemical and Drug Induced Liver Injury/etiology , Chi-Square Distribution , Female , Humans , Iran , Kaplan-Meier Estimate , Logistic Models , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Proportional Hazards Models , Renal Insufficiency, Chronic/diagnosis , Renal Insufficiency, Chronic/mortality , Retrospective Studies , Risk Assessment , Risk Factors , Time Factors , Treatment Outcome , Tuberculosis/complications , Tuberculosis/diagnosis , Tuberculosis/mortality
2.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-118397

ABSTRACT

While airways reactivity is among the characteristics of asthma, is not considered a sufficient condition diagnostically and the methacholine challenge is a non-specific diagnostic aid in cases of chronic cough and reactive airways disease. The aim of this cross-sectional study was to determine the metacholine response positivity and diagnosis of asthma in patients with chronic cough presenting to a hospital in Tehran during 2007 and 2008. Of 101 patients with chronic cough [with no history of sinusitis, recent pulmonary infection, bronchitis, gasteroesophageal reflux or underlying pulmonary conditions], 51.5% showed reactive airways disease to the methacholine test, 40.6% were unreactive and 7.9% were indeterminate. A positive methacholine challenge test was positively correlated with new wheezing. Although the methacholine challenge test is not a primary test for evaluating chronic cough, if no other reason for chronic cough is found, it may be a guiding test for asthma


Subject(s)
Cough , Chronic Disease , Cross-Sectional Studies , Asthma , Respiratory Sounds , Methacholine Chloride
3.
Iran J Public Health ; 41(4): 63-8, 2012.
Article in English | MEDLINE | ID: mdl-23113166

ABSTRACT

BACKGROUND: This study was to determine common methods to treat addiction used by patients checked into Outpatient Treatment and Rehabilitation Clinics in Tehran. METHODS: The study was conducted in Social Security affiliated outpatient clinics including three governmental and several private centers in 22 districts of Tehran. Demographic data, personal information, social characteristics and information regarding prevention, treatment, and follow-up records of 1,372 patients were obtained and analyzed. RESULTS: A majority of cases referring to the treatment centers were male (95.2%). Patients were 14 to 75 yr (mean 35.48 ± 10.57 yr); 61.7% were married and lived in rented homes in the city; 938/1372 (68.4%) had at least one previous attempt failure when seeking re-treatment. A majority of them (77.8%) had a history of 1 to 4 quit attempts; a number 63.1% had an abstinence period of 1 week to 6 months. CONCLUSION: The majority of our understudy subjects had a history of previous attempts to treat their addiction with a maximum abstinence period of 6 months.

4.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-118538

ABSTRACT

This cross-sectional survey aimed to provide an overview of tobacco control strategies in the countries of the Eastern Mediterranean Region [EMR]. A questionnaire to collate data on implementation of 6 major policies was developed based on the previously published Tobacco Control Scale and using MPOWER measures of the WHO Tobacco Free Initiative and the Tobacco Atlas. Only 3 of the 21 countries scored higher than 50 out of 100: Islamic Republic of Iran [61], Jordan [55] and Egypt [51]. More than half of countries scored less than 26. Highest scores were achieved by Afghanistan in cigarette pricing, Oman in smoking bans in public places, Islamic Republic of Iran in budgeting, prohibition of advertisements and health warnings against smoking and Syrian Arab Republic, Tunisia and Kuwait in tobacco cessation programmes. The low mean total score in EMR countries [29.7] compared with European countries [47.2] highlights the need for better future planning and policy-making for tobacco control in the Region


Subject(s)
Cross-Sectional Studies , Surveys and Questionnaires , Smoking , Smoking Cessation , Tobacco Products , Nicotiana
5.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-118519

ABSTRACT

Patterns of drug resistance in recurrent cases of tuberculosis may be different than in those without a history of treatment. In this retrospective study, the drug resistance pattern and outcome of treatment with DOTS category I [CAT I] regimen was compared in 63 recurrent cases and 872 new cases of pulmonary tuberculosis from April 2003 to January 2008 at the National Research Institute of Tuberculosis and Lung Disease in Tehran, Islamic Republic of Iran. Resistance to isoniazid and ethambutol was significantly more common in recurrent cases, but there were no differences in rates of resistance to rifampin, pyrazinamide, streptomycin or the rate of multi-drug resistant strains. Resistance to streptomycin was the most common. No significant differences in treatment outcome and deaths were found between the 2 groups. Due to the low frequency of multi-drug resistance in the recurrent cases, a CAT I regimen may be suitable for empirical therapy before drug sensitivity results become available


Subject(s)
Tuberculosis, Multidrug-Resistant , Drug Resistance , Treatment Outcome , Recurrence , Retrospective Studies , Tuberculosis, Pulmonary , Isoniazid , Ethambutol , Rifampin , Pyrazinamide , Streptomycin , Tuberculosis
6.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-118486

ABSTRACT

The aim of this cross-sectional observational study was to address the health care situation in regard to smoking cessation efforts and expenditure, and to provide a basis for future studies and for implementing tobacco control programmes throughout the Eastern Mediterranean Region of the World Health Organization. Information collected included methods and cost of services for tobacco cessation from all 16 participating countries. In 10 countries, cessation programmes were directed by primary physicians. In 13 countries, nicotine gum and in 14 countries nicotine patches were accessible in pharmacies. Bupropion was available at pharmacies [with a written prescription] in 6 countries and varenicline in 7 countries. However, the mean cost of each service was significantly higher than the price of a pack of cigarettes. In countries with support services for tobacco cessation, directors need to provide care at the society level that is considerably less costly and widely accessible


Subject(s)
Costs and Cost Analysis , Surveys and Questionnaires , Cross-Sectional Studies , Tobacco Use Cessation Devices , Smoking Cessation
7.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-118334

ABSTRACT

This cross-sectional survey aimed to provide an overview of tobacco control strategies in the countries of the Eastern Mediterranean Region [EMR]. A questionnaire to collate data on implementation of 6 major policies was developed based on the previously published Tobacco Control Scale and using MPOWER measures of the WHO Tobacco Free Initiative and the Tobacco Atlas. Only 3 of the 21 countries scored higher than 50 out of 100: Islamic Republic of Iran [61], Jordan [55] and Egypt [51]. More than half of countries scored less than 26. Highest scores were achieved by Afghanistan in cigarette pricing, Oman in smoking bans in public places, Islamic Republic of Iran in budgeting, prohibition of advertisements and health warnings against smoking and Syrian Arab Republic, Tunisia and Kuwait in tobacco cessation programmes. The low mean total score in EMR countries [29.7] compared with European countries [47.2] highlights the need for better future planning and policy-making for tobacco control in the Region

8.
Transpl Infect Dis ; 12(3): 258-60, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20015115

ABSTRACT

Pulmonary complications are not infrequent after heart transplantation. Kaposi sarcoma is a vascular tumor that can involve the skin as well as visceral organs. We describe a case of visceral and cutaneous Kaposi sarcoma that presented with diffuse bilateral pulmonary infiltration and breathlessness 6 month after heart transplantation. Following modulation of the immunosuppressive regimen and addition of chemotherapy, the patient had an excellent response and has had an uneventful 1-year follow-up.


Subject(s)
Heart Transplantation/adverse effects , Lung Neoplasms/etiology , Sarcoma, Kaposi/etiology , Skin Neoplasms/etiology , Herpesvirus 8, Human/classification , Herpesvirus 8, Human/genetics , Herpesvirus 8, Human/isolation & purification , Humans , Lung/pathology , Lung Neoplasms/pathology , Lung Neoplasms/virology , Male , Middle Aged , Sarcoma, Kaposi/pathology , Sarcoma, Kaposi/virology , Skin Neoplasms/pathology , Skin Neoplasms/virology
9.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-117768

ABSTRACT

We compared the effectiveness of 2 treatment regimens for isoniazid-resistant tuberculosis [TB] in 42 patients attending a TB referral centre in the Islamic Republic of Iran. The patients were divided into 2 treatment groups: 26 received the 6-month standard HRZE treatment and 16 received a modified treatment of RZE for 6 months. There were no significant differences in age or sex of the groups. With the standard method of treatment, 21 [80.8%] patients were cured, 4 [15.4%] resulted in treatment failure, and 1 [3.8%] died. In the modified treatment group, 16 [100%] patients were cured. These differences were not statistically significantly different [P = 0.194]


Subject(s)
Isoniazid , Antitubercular Agents , Mycobacterium tuberculosis , Treatment Outcome , Tuberculosis, Multidrug-Resistant
11.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-117534

ABSTRACT

To study the participation of the private sector in detection and diagnosis of tuberculosis, all suspected cases referring to 4 private laboratories in Tehran for acid-fast bacillus examination during 2002-03 were documented. Of 9037 cases enrolled in the study, 637 had positive examination results [7.1%]. Of these 531 [5.9%] cases were direct smear-positive and 489 [5.4%] were culture-positive. Data from the Iranian Ministry of Health showed 9479 cases referred to government laboratories in Tehran urban area during the study period, 208 [2.2%] of which were positive. This larger than expected proportion of TB patients who are detected and managed by the private sector indicates that much closer cooperation is needed between the public and private sectors


Subject(s)
Laboratories , Cross-Sectional Studies , Age Distribution , Private Sector , Tuberculosis
12.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-117436

ABSTRACT

This case series describes the clinical and laboratory profile of 15 patients with tuberculosis [TB] HIV coinfection admitted to a referral centre in the Islamic Republic of Iran. Most of the patients [13] were male; the mean age was 36.9 years. Intravenous drug use was the route of transmission for all males and heterosexual intercourse for the 2 females; 12 patients had a history of imprisonment. All patients had pulmonary TB; 13 were smear-positive and all except 1 had atypical radiological presentation. Drug-induced hepatitis occurred in 3 patients and 12 had hepatitis C coinfection. Five patients died. The mean CD4 count was 229.2 [SD 199.5] cells/mm[3] and 78.6% had CD4 count < 350. TB may be an AIDS-defining illness in this country


Subject(s)
Tuberculosis , HIV , CD4 Lymphocyte Count , Enzyme-Linked Immunosorbent Assay , Hepatitis C , Surveys and Questionnaires , Microbial Sensitivity Tests , Flow Cytometry
13.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-117342

ABSTRACT

This study in 2003 determined the prevalence of smoking and its associated factors among high-school students in Tehran, Islamic Republic of Iran. Out of 1095 students aged 14-18 years, 29% [31% boys, 26% girls] were occasional and 5% [6% boys and 2% girls] daily smokers. Among occasional smokers, 21% had family members who also smoked, whereas for students who had never tried smoking, no family members smoked. Of 316 occasional smokers, 12% lived with a single parent compared with only 5% of never smokers. Regression analysis showed that significant risk factors for daily smoking were: having a brother or sister who smokes [OR = 8.58] and having more than 1 family member who smokes [OR = 6.33]


Subject(s)
Smoking , Prevalence , Risk Factors , Cross-Sectional Studies , Students
14.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-117298

ABSTRACT

Nearly 18% of tuberculosis [TB] cases have only extrapulmonary manifestations. Breast tuberculosis is a rare type of extrapulmonary TB. This paper reports 4 cases of breast TB confirmed either pathologically or mycobacteriologically or both. These reports showed that TB should always be considered first in the differential diagnosis of granulomatous mastitis in TB-endemic areas. Therapy included at least 6 months of anti-TB medication and surgery when indicated


Subject(s)
Breast , Tuberculosis , Mastitis , Biopsy, Fine-Needle , Ultrasonography, Mammary , Breast Diseases
15.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-119168

ABSTRACT

The study assessed reasons for delay between patient's first symptoms of tuberculosis and initiation of therapy. Fifty newly diagnosed cases of pulmonary tuberculosis admitted to the NRITLD in Teheran were studied. Mean patient delay before consulting a physician was 12.5 +/- 10 days, significantly higher among men than women. Mean delay until the physicians' diagnosis was 93 +/- 80 days, significantly higher for women than for men. Almost no treatment delay was observed [mean 4 +/- 4 days after diagnosis had been confirmed]. The major delay was the time taken by physicians to diagnose tuberculosis in symptomatic patients. An active and effective national tuberculosis programme is needed in the Islamic Republic of Iran, with integration of the programme in medical school curricula and in continuing professional training


Subject(s)
Antitubercular Agents , Education, Medical, Continuing , Health Care Surveys , Health Services Accessibility , Health Knowledge, Attitudes, Practice , Patient Acceptance of Health Care , Patient Education as Topic , Sex Factors , Tuberculosis, Pulmonary
SELECTION OF CITATIONS
SEARCH DETAIL
...